Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only-Reference-Cited by-同舟云学术

Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only

Published:2011 Issue: Volume:2011 Page:1-7
ISSN:1687-9589
Container-title:Obstetrics and Gynecology International
language:en
Short-container-title:Obstetrics and Gynecology International

Author:

Jobsen Jan J.¹,Naudin ten Cate Lambert²,Lybeert Marnix L. M.³,Scholten Astrid⁴,van der Steen-Banasik Elzbieta M.⁵,van der Palen Job⁶⁷,Stenfert Kroese Marika C.⁸,Slot Annerie⁹,Schutter Eltjo M. J.¹⁰,Siesling Sabine¹¹

Affiliation:

1. Department of Radiation Oncology, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER Enschede, The Netherlands

2. Laboratorium Pathologie Oost Nederland, 7512 ER Enschede, The Netherlands

3. Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands

4. Department of Clinical Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands

5. Arnhem Radiotherapeutic Institute, Arnhem, The Netherlands

6. Department of Research Methodology, Measurement, and Data Analysis, Faculty of Behavioral Science, University of Twente, 7500 AE Enschede, The Netherlands

7. Department of Clinical Epidemiology, Medisch Spectrum Twente, 7513 ER Enschede, The Netherlands

8. Radiotherapy Institute Steden en Omstreken, Deventer, The Netherlands

9. Radiotherapy Institute Friesland, Leeuwarden, The Netherlands

10. Department of Obstetrics and Gynaecology, Medisch Spectrum Twente, 7513 ER Enschede, The Netherlands

11. Comprehensive Cancer Centre North East, Enschede/Groningen, The Netherlands

Abstract

Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma.Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed.Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (P=.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (P=.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa.Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa.

Publisher

Hindawi Limited

Subject

Obstetrics and Gynecology

Link

http://downloads.hindawi.com/journals/ogi/2011/962518.pdf

Reference20 articles.

1. TNM Atlas,1997

2. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis

3. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both;International Journal of Gynecologic Cancer;2024-07-29

2. Prediction of recurrence risk in endometrial cancer with multimodal deep learning;Nature Medicine;2024-05-24

3. HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancer;2023-11-27

4. FIGO staging of endometrial cancer: 2023;International Journal of Gynecology & Obstetrics;2023-06-20

5. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts;The Lancet Digital Health;2023-02